These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6773054)
1. Connective tissue activation. XVI. Detection of a human platelet-derived connective tissue activating peptide (CTAP-III) in human sera and plasma and in synovial fluids and tissues. Sloan TB; Weiss JJ; Anderson B; Ritchie JC; Whitney SL; Castor CW Proc Soc Exp Biol Med; 1980 Jul; 164(3):267-74. PubMed ID: 6773054 [No Abstract] [Full Text] [Related]
2. Connective tissue activation. XVII. Radioimmunoassay of a human platelet derived connective tissue activating peptide (CTAP-III) and specificities of anti-CTAP-III sera. Weiss JJ; Meyers S; Castor CW; Donakowski C; Anderson B Clin Chim Acta; 1980 Dec; 108(3):425-33. PubMed ID: 7471473 [TBL] [Abstract][Full Text] [Related]
3. Connective tissue activation. XXII. A platelet growth factor (connective tissue-activating peptide-III) in human growth hormone-deficient patients. Castor CW; Cobel-Geard SR; Hossler PA; Kelch RP J Clin Endocrinol Metab; 1981 Jan; 52(1):128-32. PubMed ID: 6778888 [TBL] [Abstract][Full Text] [Related]
4. Connective tissue activation. XXXIII. Biologically active cleavage products of CTAP-III from human platelets. Castor CW; Walz DA; Ragsdale CG; Hossler PA; Smith EM; Bignall MC; Aaron BP; Mountjoy K Biochem Biophys Res Commun; 1989 Sep; 163(2):1071-8. PubMed ID: 2783111 [TBL] [Abstract][Full Text] [Related]
5. Connective tissue activation. XXXV. Detection of connective tissue activating peptide-III isoforms in synovium from osteoarthritis and rheumatoid arthritis patients: patterns of interaction with other synovial cytokines in cell culture. Castor CW; Smith EM; Hossler PA; Bignall MC; Aaron BP Arthritis Rheum; 1992 Jul; 35(7):783-93. PubMed ID: 1622417 [TBL] [Abstract][Full Text] [Related]
6. Measurement of beta-thromboglobulin connective tissue activating peptide-III platelet antigen concentrations in pathologic synovial fluids. Myers SL; Christine TA J Rheumatol; 1982; 9(1):6-12. PubMed ID: 6177854 [TBL] [Abstract][Full Text] [Related]
7. Connective tissue activation. XXXI. Identification of two molecular forms of a human mesenchymal cell-derived growth factor, connective tissue activating peptide-V. Cabral AR; Castor CW Arthritis Rheum; 1987 Dec; 30(12):1382-92. PubMed ID: 3325065 [TBL] [Abstract][Full Text] [Related]
8. Connective tissue activation. XIV. Composition and actions of a human platelet autacoid mediator. Castor CW; Ritchie JC; Williams CH; Scott ME; Whitney SL; Myers SL; Sloan TB; Anderson BE Arthritis Rheum; 1979 Mar; 22(3):260-72. PubMed ID: 420716 [TBL] [Abstract][Full Text] [Related]
9. Connective tissue activation. XV. Stimulation of glycosaminoglycan and DNA synthesis by a polymorphonuclear leukocyte factor. Myers SL; Castor CW Arthritis Rheum; 1980 May; 23(5):556-63. PubMed ID: 7378085 [TBL] [Abstract][Full Text] [Related]
10. Connective tissue activation XIX. Plasma levels of the CTAP-III platelet antigen in rheumatoid arthritis. Myers SL; Hossler PA; Castor CW J Rheumatol; 1980; 7(6):814-9. PubMed ID: 7205823 [TBL] [Abstract][Full Text] [Related]
11. Connective tissue activation. XI. Stimulation of glycosaminoglycan and DNA formation by a platelet factor. Castor CW; Ritchie JC; Scott ME; Whitney SL Arthritis Rheum; 1977 Apr; 20(3):859-68. PubMed ID: 856217 [TBL] [Abstract][Full Text] [Related]
12. Connective tissue activation. XXXVI. The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: characteristics in patients with rheumatic, renal, and arterial disease. Castor CW; Andrews PC; Swartz RD; Ellis SG; Hossler PA; Clark MR; Matteson EL; Sachter EF Arthritis Rheum; 1993 Aug; 36(8):1142-53. PubMed ID: 8343190 [TBL] [Abstract][Full Text] [Related]
13. Connective tissue activation. XX. Stimulation of prostaglandin secretion by mediators from lymphocytes (CTAP-I) and platelets (CTAP-III). Castor CW; Pek S Arthritis Rheum; 1981 Mar; 24(3):504-9. PubMed ID: 6971101 [No Abstract] [Full Text] [Related]
14. Connective tissue activation XXXVIII: heparin/heparanase activity of human platelets resides in a high molecular weight protein, not in connective tissue activating peptide III. Castor CW; Kotlyar A; Edwards BE J Rheumatol; 2002 Nov; 29(11):2337-44. PubMed ID: 12415589 [TBL] [Abstract][Full Text] [Related]
15. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor. Castor CW; Miller JW; Walz DA Proc Natl Acad Sci U S A; 1983 Feb; 80(3):765-9. PubMed ID: 6572368 [TBL] [Abstract][Full Text] [Related]
16. Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology. Pilatova K; Greplova K; Demlova R; Bencsikova B; Klement GL; Zdrazilova-Dubska L J Hematol Oncol; 2013 Jun; 6():42. PubMed ID: 23800319 [TBL] [Abstract][Full Text] [Related]
17. Connective tissue activation by synovial fluids and synovial-tissue extracts of rheumatoid arthritis patients. Takala I; Mäkisara P; Kulonen E Scand J Rheumatol; 1977; 6(3):172-6. PubMed ID: 929123 [TBL] [Abstract][Full Text] [Related]